Lung Structural Changes in Chronic Obstructive Pulmonary Diseases

E-ISSN： 1875-5933|4|6|643-649

ISSN： 1568-010X

Source： Current Drug Targets. Inflammation & Allergy, Vol.4, Iss.6, 2005-12, pp. : 643-649

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Chronic obstructive pulmonary disease: consequences beyond the lung

By Shrikrishna Dinesh Hopkinson Nicholas S

Clinical Medicine, Vol. 12, Iss. 1, 2012-02 ,pp. : 71-74

Royal College Of Physicians

Access to resources Recommend Favorite

Global Initiative for Chronic Obstructive Lung Diseases (GOLD)

By Hurd S.S. Pauwels R.

Pulmonary Pharmacology & Therapeutics, Vol. 15, Iss. 4, 2002-08 ,pp. : 353-355

Academic Press

Access to resources Recommend Favorite

Anti-TNF-α therapies in chronic obstructive pulmonary diseases

By Antoniu Sabina A Mihaltan Florin Ulmeanu Ruxandra

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 8, 2008-08 ,pp. : 1203-1211

Informa Healthcare

Access to resources Recommend Favorite

From Global Initiative for Chronic Obstructive Lung Disease (GOLD) Guidelines to Current Clinical Practice: An Overview of the Pharmacological Therapy of Stable Chronic Obstructive Pulmonary Disorder

By Raffaele Antonelli Incalzi

Drugs & Aging, Vol. 23, Iss. 5, 2006-01 ,pp. : 411-420

Adis International

Access to resources Recommend Favorite

Indacaterol: In Chronic Obstructive Pulmonary Disease

By Moen Marit D.

Drugs, Vol. 70, Iss. 17, 2010-12 ,pp. : 2269-2280

Adis International

Access to resources Recommend Favorite